Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Hellman

Showing results (121-130 of 136) with videos related to

Pageof 14
Sort By:
Acta Oncologica (Stockholm, Sweden)|August 21, 2014
Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasmsEva Tiensuu Janson, Halfdan Sorbye, Staffan Welin, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|August 21, 2023
Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort StudyJosefine Kjaer, Thomas E Clancy, Anders Thornell, et al.
Scientific Reports|January 28, 2016
Activating mutations in CTNNB1 in aldosterone producing adenomasTobias Åkerström, Rajani Maharjan, Holger Sven Willenberg, et al.
Medrxiv : the Preprint Server for Health Sciences|February 5, 2024
The Evolutionary History of Metastatic Pancreatic Neuroendocrine Tumours Reveals a Therapy Driven Route to High-Grade TransformationSamuel Backman, Johan Botling, Helena Nord, et al.
The Journal of Pathology|October 3, 2024
The evolutionary history of metastatic pancreatic neuroendocrine tumours reveals a therapy driven route to high-grade transformationSamuel Backman, Johan Botling, Helena Nord, et al.
Endocrine-Related Cancer|June 22, 2017
A <i>MUTYH</i> germline mutation is associated with small intestinal neuroendocrine tumorsJan P Dumanski, Chiara Rasi, Peyman Björklund, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 30, 2025
A Phase I/IIa Clinical Trial to Evaluate Safety and Adrenal Uptake of Para-Chloro-2-[<sup>18</sup>F]Fluoroethyletomidate in Healthy Volunteers and Patients with Primary AldosteronismDaniel Gillett, Russell Senanayake, James MacFarlane, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 20, 2015
Neomorphic effects of recurrent somatic mutations in Yin Yang 1 in insulin-producing adenomasM Kyle Cromer, Murim Choi, Carol Nelson-Williams, et al.
Endocrine-Related Cancer|August 20, 2015
Novel somatic mutations and distinct molecular signature in aldosterone-producing adenomasTobias Åkerström, Holger Sven Willenberg, Kenko Cupisti, et al.
Science (New York, N.Y.)|February 12, 2011
K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertensionMurim Choi, Ute I Scholl, Peng Yue, et al.
Pageof 14

Showing results (121-130 of 136) with videos related to

Sort By:
Pageof 14
Acta Oncologica (Stockholm, Sweden)|August 21, 2014
Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasmsEva Tiensuu Janson, Halfdan Sorbye, Staffan Welin, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|August 21, 2023
Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort StudyJosefine Kjaer, Thomas E Clancy, Anders Thornell, et al.
Scientific Reports|January 28, 2016
Activating mutations in CTNNB1 in aldosterone producing adenomasTobias Åkerström, Rajani Maharjan, Holger Sven Willenberg, et al.
Medrxiv : the Preprint Server for Health Sciences|February 5, 2024
The Evolutionary History of Metastatic Pancreatic Neuroendocrine Tumours Reveals a Therapy Driven Route to High-Grade TransformationSamuel Backman, Johan Botling, Helena Nord, et al.
The Journal of Pathology|October 3, 2024
The evolutionary history of metastatic pancreatic neuroendocrine tumours reveals a therapy driven route to high-grade transformationSamuel Backman, Johan Botling, Helena Nord, et al.
Endocrine-Related Cancer|June 22, 2017
A <i>MUTYH</i> germline mutation is associated with small intestinal neuroendocrine tumorsJan P Dumanski, Chiara Rasi, Peyman Björklund, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 30, 2025
A Phase I/IIa Clinical Trial to Evaluate Safety and Adrenal Uptake of Para-Chloro-2-[<sup>18</sup>F]Fluoroethyletomidate in Healthy Volunteers and Patients with Primary AldosteronismDaniel Gillett, Russell Senanayake, James MacFarlane, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 20, 2015
Neomorphic effects of recurrent somatic mutations in Yin Yang 1 in insulin-producing adenomasM Kyle Cromer, Murim Choi, Carol Nelson-Williams, et al.
Endocrine-Related Cancer|August 20, 2015
Novel somatic mutations and distinct molecular signature in aldosterone-producing adenomasTobias Åkerström, Holger Sven Willenberg, Kenko Cupisti, et al.
Science (New York, N.Y.)|February 12, 2011
K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertensionMurim Choi, Ute I Scholl, Peng Yue, et al.
Pageof 14